Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma

Digestive Surgery

Volumn 18, Issue 1, 2001, Pages 26-33

  Kubo, Shoji ^a   Hirohashi, Kazuhiro ^a   Tanaka, Hiromu ^a   Tsukamoto, Tadashi ^a   Shuto, Taichi ^a   Higaki, Ikko ^a   Takemura, Shigekazu ^a   Yamamoto, Takatsugu ^a   Nishiguchi, Shuhei ^a   Kinoshita, Hiroaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute exacerbation of hepatitis; Hepatitis B envelope antigen; Hepatitis B virus DNA; Hepatitis B virus surface antigen; Hepatocellular carcinoma; Liver resection; Multicentric carcinogenesis; Precore mutant type hepatitis B virus; Wild type hepatitis B virus

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD LEVEL; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; RECURRENT INFECTION; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE;

EID: 17744374075     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050093     Document Type: Article

References (40)

1. Viruses and hepatocellular carcinoma
2. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients
3. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis
4. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: Comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis
5. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
6. Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC
7. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma
8. Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma
9. Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma
10. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
11. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection: Incidence, predisposing factors and etiology
12. Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody positive patients
13. Spontaneous hepatitis B e antigen to antibody seroconversion and revision in Chinese patients with chronic hepatitis B virus infection
14. Spontaneous reactivation of hepatitis B in Chinese patients with HBsAg-positive chronic active hepatitis
15. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis
16. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study
17. Effect of viral status on recurrence after liver resection for hepatitis B virus-related hepatocellular carcinoma
18. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
19. Detection by ligase chain reaction of precore mutant of hepatitis B virus
20. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay
21. Quantitative analysis of wild-type and HBeAg minus hepatitis B viruses by a sequence-dependent primer extension assay
22. Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies
23. Different pattern of chromosomal allele loss in multiple hepatocellular carcinoma as evidence of their multifocal origin
24. Clinicopathologic comparison between resected hepatocellular carcinoma (HCC) and recurrent tumor: A special reference to multicentric carcinogenesis of HCC
25. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma
26. Patterns of and risk factors for factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: A special reference to multicentric carcinogenesis after operation
27. Classification of chronic hepatitis: Diagnosis, grading and staging
28. Reactivation of viral replication after liver resection in patients infected with hepatitis B virus
29. Transection of the oesophagus for bleeding oesophageal varices
30. Clonal origin of recurrent hepatocellular carcinomas
31. Multicentric independent development of hepatocellular carcinoma revealed by analysis of hepatitis B virus integration pattern
32. Hepatitis virus-related hepatocarcinogenesis
33. Immunohistochemical study of adhesion molecules in liver inflammation
34. Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan
35. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma
36. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte Class B and C cirrhosis
37. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
38. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas
39. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma